BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1227883)

  • 1. [Pharmacology of a new anti-angina preparation, nonachlazin].
    Kaverdina NV; Markova GA
    Farmakol Toksikol; 1975; 38(2):173-7. PubMed ID: 1227883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of the antianginal action of nonachlazine].
    Chumburidze VB
    Farmakol Toksikol; 1976; 39(1):46-50. PubMed ID: 943317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of nonachlazine on the frequency and amplitude of isolated atrium contraction].
    Senova ZP
    Biull Eksp Biol Med; 1977 Mar; 83(3):298-300. PubMed ID: 851633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the new calcium antagonist monatepil on cardiac function and myocardial oxygen supply and demand in animals.
    Kataoka T; Nose I; Honda Y; Yamada T; Hatano N; Masuda Y; Hosoki K; Karasawa T
    Arzneimittelforschung; 1993 Dec; 43(12):1303-9. PubMed ID: 8141817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters.
    Ernest K
    Pol J Pharmacol Pharm; 1975; 27(4):381-98. PubMed ID: 1166019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of action of nonachlazin on nervous regulation of coronary circulation].
    Bendikov EA; Gan'shina TS
    Biull Eksp Biol Med; 1976 Mar; 81(3):319-22. PubMed ID: 953279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of action of nonachlazine].
    Oganesian NM; Oganesian SS; Varosian MA; Bagramian IG; Barinian SB
    Farmakol Toksikol; 1981; 44(3):283-7. PubMed ID: 7286184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of ethmosine].
    Kaverina NV; Senova ZP; Mitrofanov VS; Runova MF
    Farmakol Toksikol; 1972; 35(2):182-5. PubMed ID: 4401791
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the effect of ildamen and nonachlazin on the blood supply and activities of the heart].
    Kaverina NV; Chichkanov GG; Chumburidze VB
    Kardiologiia; 1978 Mar; 18(3):88-93. PubMed ID: 642245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of nonachlazine and oxyfedrine on coronary circulation in dogs].
    Kaverina NV; Chichkanov GG; Chumburidze VB; Matsievskiĭ DD
    Biull Eksp Biol Med; 1977 Jan; 83(1):34-8. PubMed ID: 851604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Actions of sparteine and sparteine derivatives on the heart and circulation].
    Raschack M
    Arzneimittelforschung; 1974 May; 24(5):753-9. PubMed ID: 4408029
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride].
    Hapke HJ; Prigge E
    Arzneimittelforschung; 1976; 26(10):1849-57. PubMed ID: 1037204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacology of antiarrhythmia agents: the new aspects].
    Kaverina NV; Chichkanov GG
    Eksp Klin Farmakol; 2003; 66(2):46-52. PubMed ID: 12962048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mechanism of nonachlazine on cardiac activity and blood supply].
    Kaverina NV; Griglevskiĭ R; Basaeva AI; Markova GA; Chumburidze VB
    Biull Eksp Biol Med; 1975 Nov; 80(11):48-50. PubMed ID: 1218260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of imipramine on the vasomotor tone, blood supply and activity of the heart].
    Chichkanov GG
    Farmakol Toksikol; 1977; 40(6):710-4. PubMed ID: 598497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of a new antiarrhythmic drug, Craviten (M-71) on coronary flow.
    Banaszkiewicz W; Chodera A
    Pol J Pharmacol Pharm; 1980; 32(6):849-53. PubMed ID: 6787574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of alkyl substitution in drugs. XIX. Synthesis and pharmacological properties of a series of 1-(diarylmethoxy)-3-(isopropylamino)-2-propanol hydrochlorides showing antiarrhythmic activity.
    De Vries J; Nauta WT; Timmerman H; van Hell G; Mulder D
    Arzneimittelforschung; 1968 Sep; 18(9):1200-3. PubMed ID: 5755937
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacology of the new antihistaminic 9,9-dioxopromethazine (Prothanon)].
    Bartsch R; Nowak R; Femmer K; Stade K
    Pharmazie; 1970 Feb; 25(2):91-6. PubMed ID: 4393060
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
    Goldshteĭne GKh; Chichkanov GG
    Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.